San Diego-based mostly Viking Therapeutics marked by itself as a significant competitor while in the weight loss drug industry in February after revealing promising data from the mid-stage trial of experimental drug VK2735, which suggested it rivaled—and outperformed—Novo and Lilly drugs when given as being a weekly injection As well as in Marc